Various types of electrochemical biosensors for leukemia detection and therapeutic approaches

Supat Chupradit; Mahyuddin KM Nasution; Heshu Sulaiman Rahman; Wanich Suksatan; Abduladheem Turki Jalil; Walid Kamal Abdelbasset; Dmitry Bokov; Alexander Markov; Irina N. Fardeeva; Gunawan Widjaja; Mohammed Nader Shalaby; Marwan Mahmood Saleh; Yasser Fakri Mustafa; A. Surendar; Ramtin Bidares

doi:10.1016/j.ab.2022.114736

Various types of electrochemical biosensors for leukemia detection and therapeutic approaches

Supat Chupradit
, Mahyuddin KM Nasution
, Heshu Sulaiman Rahman
, Wanich Suksatan
, Abduladheem Turki Jalil
, Walid Kamal Abdelbasset
, Dmitry Bokov
, Alexander Markov
, Irina N. Fardeeva
, Gunawan Widjaja
, Mohammed Nader Shalaby
, Marwan Mahmood Saleh
, Yasser Fakri Mustafa
, A. Surendar
, Ramtin Bidares

Physical Therapy and Health Rehabilitation

Research output: Contribution to journal › Review article › peer-review

68 Scopus citations

Abstract

Leukemia often initiates following dysfunctions in hematopoietic stem cells lineages. Various types of leukemia, including acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), acute promyelocytic leukemia (APL), and human T-cell leukemia/lymphoma virus type 1 (HTLV-1) can thus call for different diagnosis and treatment options. One of the most important subjects in leukemia is the early detection of the disease for effective therapeutic purposes. In this respect, biosensors detecting the molecules of deoxyribonucleic acid (DNA) as analytes are called genosensors or DNA biosensors. Electrochemical sensors, as the most significant approach, also involve reacting of chemical solutions with sensors to generate electrical signals proportional to analyte concentrations. Biosensors can further help detect cancer cells in the early stages of the disease. Moreover, electrochemical biosensors, developed based on various nanomaterials (NMs), can increase sensitivity to the detection of leukemia-related genes, e.g., BCR/ABL as a fusion gene and promyelocytic leukemia/retinoic acid receptor alpha (PML/RARα). Therefore, the present review reflects on previous studies recruiting different NMs for leukemia detection.

Original language	English
Article number	114736
Journal	Analytical Biochemistry
Volume	654
DOIs	https://doi.org/10.1016/j.ab.2022.114736
State	Published - 1 Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Biosensor
Electrochemical
Leukemia
Nanomaterial

Access to Document

10.1016/j.ab.2022.114736

Cite this

Chupradit, S., KM Nasution, M., Rahman, H. S., Suksatan, W., Turki Jalil, A., Abdelbasset, W. K., Bokov, D., Markov, A., Fardeeva, I. N., Widjaja, G., Shalaby, M. N., Saleh, M. M., Mustafa, Y. F., Surendar, A., & Bidares, R. (2022). Various types of electrochemical biosensors for leukemia detection and therapeutic approaches. Analytical Biochemistry, 654, Article 114736. https://doi.org/10.1016/j.ab.2022.114736

@article{15d546ca8de74a3ea26786bf3f600e33,

title = "Various types of electrochemical biosensors for leukemia detection and therapeutic approaches",

abstract = "Leukemia often initiates following dysfunctions in hematopoietic stem cells lineages. Various types of leukemia, including acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), acute promyelocytic leukemia (APL), and human T-cell leukemia/lymphoma virus type 1 (HTLV-1) can thus call for different diagnosis and treatment options. One of the most important subjects in leukemia is the early detection of the disease for effective therapeutic purposes. In this respect, biosensors detecting the molecules of deoxyribonucleic acid (DNA) as analytes are called genosensors or DNA biosensors. Electrochemical sensors, as the most significant approach, also involve reacting of chemical solutions with sensors to generate electrical signals proportional to analyte concentrations. Biosensors can further help detect cancer cells in the early stages of the disease. Moreover, electrochemical biosensors, developed based on various nanomaterials (NMs), can increase sensitivity to the detection of leukemia-related genes, e.g., BCR/ABL as a fusion gene and promyelocytic leukemia/retinoic acid receptor alpha (PML/RARα). Therefore, the present review reflects on previous studies recruiting different NMs for leukemia detection.",

keywords = "Biosensor, Electrochemical, Leukemia, Nanomaterial",

author = "Supat Chupradit and \{KM Nasution\}, Mahyuddin and Rahman, \{Heshu Sulaiman\} and Wanich Suksatan and \{Turki Jalil\}, Abduladheem and Abdelbasset, \{Walid Kamal\} and Dmitry Bokov and Alexander Markov and Fardeeva, \{Irina N.\} and Gunawan Widjaja and Shalaby, \{Mohammed Nader\} and Saleh, \{Marwan Mahmood\} and Mustafa, \{Yasser Fakri\} and A. Surendar and Ramtin Bidares",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",

year = "2022",

month = oct,

day = "1",

doi = "10.1016/j.ab.2022.114736",

language = "English",

volume = "654",

journal = "Analytical Biochemistry",

issn = "0003-2697",

publisher = "Academic Press Inc.",

}

Chupradit, S, KM Nasution, M, Rahman, HS, Suksatan, W, Turki Jalil, A, Abdelbasset, WK, Bokov, D, Markov, A, Fardeeva, IN, Widjaja, G, Shalaby, MN, Saleh, MM, Mustafa, YF, Surendar, A & Bidares, R 2022, 'Various types of electrochemical biosensors for leukemia detection and therapeutic approaches', Analytical Biochemistry, vol. 654, 114736. https://doi.org/10.1016/j.ab.2022.114736

TY - JOUR

T1 - Various types of electrochemical biosensors for leukemia detection and therapeutic approaches

AU - Chupradit, Supat

AU - KM Nasution, Mahyuddin

AU - Rahman, Heshu Sulaiman

AU - Suksatan, Wanich

AU - Turki Jalil, Abduladheem

AU - Abdelbasset, Walid Kamal

AU - Bokov, Dmitry

AU - Markov, Alexander

AU - Fardeeva, Irina N.

AU - Widjaja, Gunawan

AU - Shalaby, Mohammed Nader

AU - Saleh, Marwan Mahmood

AU - Mustafa, Yasser Fakri

AU - Surendar, A.

AU - Bidares, Ramtin

PY - 2022/10/1

Y1 - 2022/10/1

N2 - Leukemia often initiates following dysfunctions in hematopoietic stem cells lineages. Various types of leukemia, including acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), acute promyelocytic leukemia (APL), and human T-cell leukemia/lymphoma virus type 1 (HTLV-1) can thus call for different diagnosis and treatment options. One of the most important subjects in leukemia is the early detection of the disease for effective therapeutic purposes. In this respect, biosensors detecting the molecules of deoxyribonucleic acid (DNA) as analytes are called genosensors or DNA biosensors. Electrochemical sensors, as the most significant approach, also involve reacting of chemical solutions with sensors to generate electrical signals proportional to analyte concentrations. Biosensors can further help detect cancer cells in the early stages of the disease. Moreover, electrochemical biosensors, developed based on various nanomaterials (NMs), can increase sensitivity to the detection of leukemia-related genes, e.g., BCR/ABL as a fusion gene and promyelocytic leukemia/retinoic acid receptor alpha (PML/RARα). Therefore, the present review reflects on previous studies recruiting different NMs for leukemia detection.

AB - Leukemia often initiates following dysfunctions in hematopoietic stem cells lineages. Various types of leukemia, including acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), acute promyelocytic leukemia (APL), and human T-cell leukemia/lymphoma virus type 1 (HTLV-1) can thus call for different diagnosis and treatment options. One of the most important subjects in leukemia is the early detection of the disease for effective therapeutic purposes. In this respect, biosensors detecting the molecules of deoxyribonucleic acid (DNA) as analytes are called genosensors or DNA biosensors. Electrochemical sensors, as the most significant approach, also involve reacting of chemical solutions with sensors to generate electrical signals proportional to analyte concentrations. Biosensors can further help detect cancer cells in the early stages of the disease. Moreover, electrochemical biosensors, developed based on various nanomaterials (NMs), can increase sensitivity to the detection of leukemia-related genes, e.g., BCR/ABL as a fusion gene and promyelocytic leukemia/retinoic acid receptor alpha (PML/RARα). Therefore, the present review reflects on previous studies recruiting different NMs for leukemia detection.

KW - Biosensor

KW - Electrochemical

KW - Leukemia

KW - Nanomaterial

UR - https://www.scopus.com/pages/publications/85130952782

U2 - 10.1016/j.ab.2022.114736

DO - 10.1016/j.ab.2022.114736

M3 - Review article

C2 - 35588855

AN - SCOPUS:85130952782

SN - 0003-2697

VL - 654

JO - Analytical Biochemistry

JF - Analytical Biochemistry

M1 - 114736

ER -

Various types of electrochemical biosensors for leukemia detection and therapeutic approaches

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this